WuXi STA’s drug product site in Wuxi City offers a full range of services including formulation development and manufacturing for a broad range of oral and injectable dosage forms
Industry leaders discusses the need of innovation for the Indian drug industry at BioAsia 2022.
The RTP manufacturing facility will support the company's clinical studies and early commercial launch in North America and Europe
It would be the first protein-based alternative available in Israel
Novavax' vaccine has received authorizations of the vaccine in over 170 countries
Emergency Use Authorisation application request to be submitted following one month required by FDA EUA guidance
Alzheimer's disease is a serious, progressive and devastating disease with few treatment options
First Emergency Use Listing granted by WHO for a protein-based Covid-19 vaccine
All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO
The release of this batch will secure the supply for hospitals and cancer centres that are involved in the clinical trials managed by the company
Subscribe To Our Newsletter & Stay Updated
